Sexual Functioning Study With Antidepressants

PHASE4CompletedINTERVENTIONAL
Enrollment

347

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

May 31, 2005

Study Completion Date

May 31, 2005

Conditions
Depressive Disorder, MajorMajor Depressive Disorder (MDD)
Interventions
DRUG

Bupropion Hydrochloride Extended-release

DRUG

Extended-release Venlafaxine

Trial Locations (45)

10128

GSK Investigational Site, New York

11235

GSK Investigational Site, Brooklyn

20852

GSK Investigational Site, Rockville

22908

GSK Investigational Site, Charlottesville

28209

GSK Investigational Site, Charlotte

29201

GSK Investigational Site, Columbia

29407

GSK Investigational Site, Charleston

30060

GSK Investigational Site, Marietta

30080

GSK Investigational Site, Smyrna

32216

GSK Investigational Site, Jacksonville

32806

GSK Investigational Site, Orlando

33065

GSK Investigational Site, Coral Springs

43623

GSK Investigational Site, Toledo

44109

GSK Investigational Site, Cleveland

46202

GSK Investigational Site, Indianapolis

55454

GSK Investigational Site, Minneapolis

60523

GSK Investigational Site, Oak Brook

70112

GSK Investigational Site, New Orleans

72223

GSK Investigational Site, Little Rock

73112

GSK Investigational Site, Oklahoma City

73117

GSK Investigational Site, Oklahoma City

76107

GSK Investigational Site, Fort Worth

77401

GSK Investigational Site, Bellaire

78229

GSK Investigational Site, San Antonio

78756

GSK Investigational Site, Austin

80212

GSK Investigational Site, Denver

85023

GSK Investigational Site, Phoenix

85210

GSK Investigational Site, Mesa

85251

GSK Investigational Site, Scottsdale

89146

GSK Investigational Site, Las Vegas

90210

GSK Investigational Site, Beverly Hills

91506

GSK Investigational Site, Burbank

91786

GSK Investigational Site, Upland

91942

GSK Investigational Site, La Mesa

92591

GSK Investigational Site, Temecula

94109

GSK Investigational Site, San Francisco

94598

GSK Investigational Site, Walnut Creek

97209

GSK Investigational Site, Portland

97210

GSK Investigational Site, Portland

97401

GSK Investigational Site, Eugene

98902

GSK Investigational Site, Yakima

02184

GSK Investigational Site, Braintree

01301

GSK Investigational Site, Greenfield

02865-4208

GSK Investigational Site, Lincoln

53562-2215

GSK Investigational Site, Middleton

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY